Many trials fail not because of ineffective treatments, but due to challenges in detecting treatment signals. Explore how advanced data analytics can improve ClinRO quality.

RTSM/IRT systems are essential to modern clinical trials. This guide explores how to implement and optimize them to boost efficiency, streamline operations, uphold study integrity, and ensure compliance.

As trials grow more complex, managing clinical supplies is increasingly challenging. In a recent webinar, experts discussed forecasting, GxP inventory management, and integrated solutions to overcome these hurdles.

Explore the challenges pharmaceutical companies face in implementing PROs in cancer clinical trials as outlined in the FDA’s draft guidance, as well as strategies to overcome these obstacles.

Here we examine two contrasting approaches to showcase how a centralized inventory management system is an effective tool for supporting a robust supply chain.

A global pharma leader improved supply chain efficiency and compliance by digitalizing processes with Signant's SmartSignals Supplies, achieving better visibility, traceability, and reduced errors.

A U.S.-based clinical research sponsor optimized their supply chain visibility, reduced costs and risks, and improved efficiency by replacing their manual inventory management system.

A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.

A Japan-based biotechnology company leveraged Signant SmartSignals® GxP Inventory, which improved visibility, reduced risks and costs, and optimized operations in this case study.

Signant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.